Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LNSR NASDAQ:LUNG NASDAQ:POCI NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLNSRLENSAR$5.82$5.70$5.06▼$13.47$70.42M0.8741,232 shs27,981 shsLUNGPulmonx$1.37$1.40$1.13▼$3.88$57.87M0.28325,948 shs226,120 shsPOCIPrecision Optics$5.89$4.77$3.55▼$6.15$64.44M0.3169,884 shs59,084 shsZJYLJin Medical International$2.42$2.29$1.64▼$17.18$18.95M7.24849,058 shs70,595 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLNSRLENSAR0.00%+3.93%+5.05%-43.27%-53.44%LUNGPulmonx0.00%-10.46%+7.87%-14.91%-54.79%POCIPrecision Optics0.00%+1.55%+23.48%+37.94%+26.07%ZJYLJin Medical International0.00%-2.02%-1.22%-3.97%-82.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLNSRLENSAR$5.82$5.70$5.06▼$13.47$70.42M0.8741,232 shs27,981 shsLUNGPulmonx$1.37$1.40$1.13▼$3.88$57.87M0.28325,948 shs226,120 shsPOCIPrecision Optics$5.89$4.77$3.55▼$6.15$64.44M0.3169,884 shs59,084 shsZJYLJin Medical International$2.42$2.29$1.64▼$17.18$18.95M7.24849,058 shs70,595 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLNSRLENSAR0.00%+3.93%+5.05%-43.27%-53.44%LUNGPulmonx0.00%-10.46%+7.87%-14.91%-54.79%POCIPrecision Optics0.00%+1.55%+23.48%+37.94%+26.07%ZJYLJin Medical International0.00%-2.02%-1.22%-3.97%-82.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLNSRLENSAR 2.33Hold$10.0071.82% UpsideLUNGPulmonx 2.43Hold$5.58307.54% UpsidePOCIPrecision Optics 1.00SellN/AN/AZJYLJin Medical International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest ZJYL, LNSR, LUNG, and POCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/5/2026POCIPrecision Optics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/11/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)4/30/2026LUNGPulmonx D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.004/21/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/15/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)4/1/2026LNSRLENSAR Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$10.003/17/2026LNSRLENSAR BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$10.00(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLNSRLENSAR$58.44M1.21N/AN/A($2.18) per share-2.67LUNGPulmonx$90.50M0.64N/AN/A$1.31 per share1.05POCIPrecision Optics$19.09M3.38N/AN/A$1.60 per share3.68ZJYLJin Medical International$20.69M0.92$0.18 per share13.21$3.78 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLNSRLENSAR-$34.28M-$0.58N/AN/AN/A50.94%-183.19%42.26%8/6/2026 (Estimated)LUNGPulmonx-$54M-$1.30N/AN/AN/A-60.09%-92.94%-39.80%7/29/2026 (Estimated)POCIPrecision Optics-$5.78M-$0.63N/AN/AN/A-17.03%-37.47%-19.96%N/AZJYLJin Medical International$1.19MN/AN/AN/AN/AN/AN/AN/AN/ALatest ZJYL, LNSR, LUNG, and POCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q3 2026POCIPrecision OpticsN/A-$0.01N/A-$0.01N/A$8.71 million5/8/2026Q1 2026LNSRLENSAR$0.1850$1.56+$1.3750N/A$13.40 million$13.43 million4/29/2026Q1 2026LUNGPulmonx-$0.33-$0.33N/A-$0.33$20.43 million$20.59 million3/31/2026Q4 2025LNSRLENSAR-$0.10-$0.12-$0.02-$0.12$20.30 million$16.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLNSRLENSARN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLNSRLENSARN/A2.381.08LUNGPulmonx0.814.914.04POCIPrecision Optics0.042.101.74ZJYLJin Medical InternationalN/A1.861.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLNSRLENSAR40.15%LUNGPulmonx91.04%POCIPrecision Optics13.71%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipLNSRLENSAR66.00%LUNGPulmonx6.80%POCIPrecision Optics14.40%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLNSRLENSAR11012.10 million4.12 millionOptionableLUNGPulmonx25042.24 million39.37 millionOptionablePOCIPrecision Optics8010.94 million9.37 millionNot OptionableZJYLJin Medical International2457.83 millionN/ANot OptionableZJYL, LNSR, LUNG, and POCI HeadlinesRecent News About These CompaniesJin Medical International Replaces Audit Alliance With Enrome as Independent AuditorJune 4, 2026 | tipranks.comJin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share SplitApril 10, 2026 | theglobeandmail.comJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementApril 7, 2026 | prnewswire.comJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance InitiativeMarch 11, 2026 | prnewswire.comJin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse SplitsFebruary 7, 2026 | theglobeandmail.comJin Medical CEO Fireside ChatFebruary 5, 2026 | prnewswire.comJin Medical to Host February 1 Fireside Chat as It Revamps Corporate WebsiteJanuary 28, 2026 | tipranks.comJin Medical International Ltd. To Host Management Fireside ChatJanuary 26, 2026 | prnewswire.comJin Medical Sets April Launch for High-Capacity Chuzhou Mobility Device PlantJanuary 22, 2026 | tipranks.comJin Medical Announces the Official Commencement Date of Chuzhou FacilityJanuary 22, 2026 | prnewswire.comJin Medical International Ltd. Management Plans For Fireside ChatJanuary 21, 2026 | finance.yahoo.comJin Medical International Ltd. to Host Fireside Chat on Strategic Priorities and Capital Structure on February 1, 2026January 21, 2026 | quiverquant.comQJin Medical Calls January 30 EGM to Restructure Share Capital and Adopt New Equity PlanJanuary 8, 2026 | tipranks.comJin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?November 22, 2025 | defenseworld.netDAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comJin Medical International (NASDAQ:ZJYL) Will Want To Turn Around Its Return TrendsAugust 25, 2025 | finance.yahoo.comJin Medical International Reports Decline in Revenue and Profit for H1 2025August 20, 2025 | msn.comJin Medical International Ltd News (ZJYL) - Investing.comAugust 20, 2025 | investing.comJin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, ChinaJuly 15, 2025 | quiverquant.comQJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing FacilityJuly 15, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Silver Lining of Last Week's Hims & Hers Earnings MissBy Jessica Mitacek | May 21, 2026Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionBy Jeffrey Neal Johnson | June 11, 2026Short Sellers Are Piling Into Wingstop, But Analysts See Big UpsideBy Jennifer Ryan Woods | June 10, 2026ZJYL, LNSR, LUNG, and POCI Company DescriptionsLENSAR NASDAQ:LNSR$5.82 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$5.84 +0.02 (+0.34%) As of 06/12/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Pulmonx NASDAQ:LUNG$1.37 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.38 +0.01 (+0.73%) As of 06/12/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.Precision Optics NASDAQ:POCI$5.89 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$5.87 -0.02 (-0.34%) As of 06/12/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.Jin Medical International NASDAQ:ZJYL$2.42 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$2.38 -0.04 (-1.65%) As of 06/12/2026 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? Alphabet's Most Overlooked Division Just Had a Big Week Robinhood Wants a Bigger Role in IPOs—Here's Why It Matters Viasat's Orbiting Profits: Space Force Jackpot? What to Expect From Q2 Earnings as Tech Strength Broadens ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
